/ TerminatedNot Applicable Clinical Evaluation of a SARS-CoV-2 CoviDx™COVID-19 Antigen Self-Test
Prospective study that will evaluate the clinical agreement of the CoviDx™ Self test compared to SARS-CoV-2 RT-PCR.
/ CompletedNot Applicable Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 CoviDx™ Rapid Antigen Test
Prospective study that will evaluate the clinical agreement of the CoviDx™ Rapid Antigen test compared to SARS-CoV-2 RT-PCR.
/ CompletedNot Applicable Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Prospective, multi-center, observational, blinded clinical trial to compare a new point of care (POC) SARS-CoV-2 IgG antibody test to a reference SARS-CoV-2 PCR test using fingerstick whole blood.
100 Clinical Results associated with Rapid Pathogen Screening, Inc.
0 Patents (Medical) associated with Rapid Pathogen Screening, Inc.
100 Deals associated with Rapid Pathogen Screening, Inc.
100 Translational Medicine associated with Rapid Pathogen Screening, Inc.